Key Candidiasis Drugs Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co., Inc.
- Astellas Pharma Inc.
- Novartis AG
- Bayer AG
- GlaxoSmithKline (GSK) plc
- Cidara Therapeutics, Inc.
- SCYNEXIS, Inc.
- Melinta Therapeutics, LLC
- Basilea Pharmaceutica Ltd.
- Mylan N.V. (now part of Viatris Inc.)
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Astellas Pharma US (Sub. of Astellas)
- Pacgen Life Science Corporation
- Lupin Limited
- Cipla Limited
- Alkem Laboratories
- Hikma Pharmaceuticals PLC
- Bausch Health Companies Inc.
The candidiasis drugs market is representing intensifying competition among key players, including Pfizer, Bayer, Novartis, and Merck. They are currently solidifying their leadership for the upcoming years by advancing their bioidentical formulations and adopting AI-driven drug development to enhance treatment efficacy. On the other hand, Astellas Pharma and Takeda are concentrating on developing and marketing personalized antifungal therapies. Simultaneously, they are maintaining alignment with government initiatives to further accelerate the adoption and widespread use of their portfolio, along with an enhancement in drug accessibility.
Below is the list of some prominent players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of the candidiasis drugs market was over USD 2.6 billion.
The market size for the candidiasis drugs market is projected to reach USD 4.9 billion by the end of 2035 expanding at a CAGR of 7.5% during the forecast period, i.e., between 2026 and 2035.
The major players in the market are Pfizer Inc., Merck & Co., Inc., Astellas Pharma Inc., Novartis AG, Bayer AG, GlaxoSmithKline (GSK) plc, and others.
In terms of drug class, the azoles segment is anticipated to garner the largest market share of 45.4% by 2037 and display lucrative growth opportunities during 2025-2037.
The market in North America is projected to hold the largest market share of 40.5% by the end of 2035 and provide more business opportunities in the future.
